141 related articles for article (PubMed ID: 9660096)
1. In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain.
Takahashi Y; Kusumi I; Ishikane T; Koyama T
J Neural Transm (Vienna); 1998; 105(2-3):181-91. PubMed ID: 9660096
[TBL] [Abstract][Full Text] [Related]
2. In vivo occupation of dopamine D1, D2 and serotonin (5-HT)2A receptors by sertindole in the rat brain.
Takahashi Y; Kusumi I; Ishikane T; Matsubara S; Koyama T
J Psychiatry Neurosci; 1998 May; 23(3):157-62. PubMed ID: 9595889
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
Kusumi I; Takahashi Y; Suzuki K; Kameda K; Koyama T
J Neural Transm (Vienna); 2000; 107(3):295-302. PubMed ID: 10821438
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
Matsubara S; Matsubara R; Kusumi I; Koyama T; Yamashita I
J Pharmacol Exp Ther; 1993 May; 265(2):498-508. PubMed ID: 7684443
[TBL] [Abstract][Full Text] [Related]
5. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
[TBL] [Abstract][Full Text] [Related]
6. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
Neuropharmacology; 1999 Aug; 38(8):1185-94. PubMed ID: 10462131
[TBL] [Abstract][Full Text] [Related]
7. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
8. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
Zhang W; Bymaster FP
Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
[TBL] [Abstract][Full Text] [Related]
9. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
Ohno Y; Ishida-Tokuda K; Ishibashi T; Sakamoto H; Tagashira R; Horisawa T; Yabuuti K; Matsumoto K; Kawabe A; Nakamura M
Pol J Pharmacol; 1997 Aug; 49(4):213-9. PubMed ID: 9437764
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P; Tallerico T
Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
[TBL] [Abstract][Full Text] [Related]
11. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
Ishikane T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; AssiƩ MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
14. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
15. Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
Ohno Y; Ishida-Tokuda K; Ishibashi T; Nakamura M
Pharmacol Biochem Behav; 1997 Aug; 57(4):889-95. PubMed ID: 9259021
[TBL] [Abstract][Full Text] [Related]
16. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
17. Binding profile of SM-9018, a novel antipsychotic candidate.
Kato T; Hirose A; Ohno Y; Shimizu H; Tanaka H; Nakamura M
Jpn J Pharmacol; 1990 Dec; 54(4):478-81. PubMed ID: 1982326
[TBL] [Abstract][Full Text] [Related]
18. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
19. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Matsubara R
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
[TBL] [Abstract][Full Text] [Related]
20. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]